News & Insights
Professionals
Focus Areas
Regions
Type
Sort By
Client News 2 Results
Client News
|March 12, 2025
Gunderson Dettmer Advises Tarsus Pharmaceuticals on Upsized Underwritten Public Offering
Biopharmaceutical company, Tarsus Pharmaceuticals, announces its March 2025 upsized underwritten public offering
Client News
|October 8, 2024
City Therapeutics Announces Launch with $135M Series A Financing
City Therapeutics announces its launch and $135 million Series A financing led by ARCH Ventures